132 related articles for article (PubMed ID: 30977451)
1. Comparative Drug Resistance Reversal Potential of Natural Glycosides: Potential of Synergy Niaziridin & Niazirin.
Dwivedi GR; Maurya A; Yadav DK; Khan F; Gupta MK; Gupta P; Darokar MP; Srivastava SK
Curr Top Med Chem; 2019; 19(10):847-860. PubMed ID: 30977451
[TBL] [Abstract][Full Text] [Related]
2. Synergy of clavine alkaloid 'chanoclavine' with tetracycline against multi-drug-resistant E. coli.
Dwivedi GR; Maurya A; Yadav DK; Singh V; Khan F; Gupta MK; Singh M; Darokar MP; Srivastava SK
J Biomol Struct Dyn; 2019 Mar; 37(5):1307-1325. PubMed ID: 29595093
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxy-α-tetralone and its derivative as drug resistance reversal agents in multi drug resistant Escherichia coli.
Dwivedi GR; Upadhyay HC; Yadav DK; Singh V; Srivastava SK; Khan F; Darmwal NS; Darokar MP
Chem Biol Drug Des; 2014 Apr; 83(4):482-92. PubMed ID: 24267788
[TBL] [Abstract][Full Text] [Related]
4. Drug Resistance Reversal Potential of Ursolic Acid Derivatives against Nalidixic Acid- and Multidrug-resistant Escherichia coli.
Dwivedi GR; Maurya A; Yadav DK; Khan F; Darokar MP; Srivastava SK
Chem Biol Drug Des; 2015 Sep; 86(3):272-83. PubMed ID: 25476148
[TBL] [Abstract][Full Text] [Related]
5. Antibacterial and antibiotic-modifying activities of three food plants (Xanthosoma mafaffa Lam., Moringa oleifera (L.) Schott and Passiflora edulis Sims) against multidrug-resistant (MDR) Gram-negative bacteria.
Dzotam JK; Touani FK; Kuete V
BMC Complement Altern Med; 2016 Jan; 16():9. PubMed ID: 26753836
[TBL] [Abstract][Full Text] [Related]
6. Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.
Dwivedi GR; Tiwari N; Singh A; Kumar A; Roy S; Negi AS; Pal A; Chanda D; Sharma A; Darokar MP
Appl Microbiol Biotechnol; 2016 Mar; 100(5):2311-25. PubMed ID: 26658982
[TBL] [Abstract][Full Text] [Related]
7. Total alkaloids of Sophorea alopecuroides-induced down-regulation of AcrAB-TolC efflux pump reverses susceptibility to ciprofloxacin in clinical multidrug resistant Escherichia coli isolates.
Zhou X; Jia F; Liu X; Wang Y
Phytother Res; 2012 Nov; 26(11):1637-43. PubMed ID: 22371352
[TBL] [Abstract][Full Text] [Related]
8. Novel Compound from Flowers of
Mandal SM; Chakraborty S; Sahoo S; Pyne S; Ghosh S; Chakraborty R
Infect Disord Drug Targets; 2020; 20(1):69-75. PubMed ID: 30277173
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics potentiating potential of catharanthine against superbug Pseudomonas aeruginosa.
Dwivedi GR; Tyagi R; Sanchita ; Tripathi S; Pati S; Srivastava SK; Darokar MP; Sharma A
J Biomol Struct Dyn; 2018 Dec; 36(16):4270-4284. PubMed ID: 29210342
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial and synergy of clavine alkaloid lysergol and its derivatives against nalidixic acid-resistant Escherichia coli.
Maurya A; Dwivedi GR; Darokar MP; Srivastava SK
Chem Biol Drug Des; 2013 Apr; 81(4):484-90. PubMed ID: 23290001
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of eugenol with Colistin against clinical isolated Colistin-resistant
Wang YM; Kong LC; Liu J; Ma HX
Antimicrob Resist Infect Control; 2018; 7():17. PubMed ID: 29423192
[TBL] [Abstract][Full Text] [Related]
12. Efflux inhibition by selective serotonin reuptake inhibitors in Escherichia coli.
Bohnert JA; Szymaniak-Vits M; Schuster S; Kern WV
J Antimicrob Chemother; 2011 Sep; 66(9):2057-60. PubMed ID: 21700628
[TBL] [Abstract][Full Text] [Related]
13. Effect of 1-(1-naphthylmethyl)-piperazine on antimicrobial agent susceptibility in multidrug-resistant isogenic and veterinary Escherichia coli field strains.
Marchetti ML; Errecalde J; Mestorino N
J Med Microbiol; 2012 Jun; 61(Pt 6):786-792. PubMed ID: 22345599
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.
Wang Y; Mowla R; Guo L; Ogunniyi AD; Rahman T; De Barros Lopes MA; Ma S; Venter H
Bioorg Med Chem Lett; 2017 Feb; 27(4):733-739. PubMed ID: 28129976
[TBL] [Abstract][Full Text] [Related]
15. Phytol derivatives as drug resistance reversal agents.
Upadhyay HC; Dwivedi GR; Roy S; Sharma A; Darokar MP; Srivastava SK
ChemMedChem; 2014 Aug; 9(8):1860-8. PubMed ID: 24891085
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
Liu X; Boothe DM; Thungrat K; Aly S
Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
Laudy AE; Kulińska E; Tyski S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
[TBL] [Abstract][Full Text] [Related]
18. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
[TBL] [Abstract][Full Text] [Related]
19. Synergy Potential of Indole Alkaloids and Its Derivative against Drug-resistant Escherichia coli.
Dwivedi GR; Gupta S; Maurya A; Tripathi S; Sharma A; Darokar MP; Srivastava SK
Chem Biol Drug Des; 2015 Dec; 86(6):1471-81. PubMed ID: 26132412
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
Mowla R; Wang Y; Ma S; Venter H
Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
